Cargando…
Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment
Autores principales: | Smith, Eric E., Cieslak, Alicja, Barber, Philip, Chen, Jerry, Chen, Yu‐Wei, Donnini, Ida, Edwards, Jodi D., Frayne, Richard, Field, Thalia S., Hegedus, Janka, Hanganu, Victoria, Ismail, Zahinoor, Kanji, Jamila, Nakajima, Makoto, Noor, Raza, Peca, Stefano, Sahlas, Demetrios, Sharma, Mukul, Sposato, Luciano A., Swartz, Richard H., Zerna, Charlotte, Black, Sandra E., Hachinski, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524100/ https://www.ncbi.nlm.nih.gov/pubmed/28476873 http://dx.doi.org/10.1161/JAHA.117.005568 |
Ejemplares similares
-
Trial of remote ischaemic preconditioning in vascular cognitive impairment (TRIC-VCI): protocol
por: Ganesh, Aravind, et al.
Publicado: (2020) -
Vascular Brain Lesions, Cognitive Reserve, and Their Association with Cognitive Profile in Persons with Early-Stage Cognitive Decline
por: Durrani, Romella, et al.
Publicado: (2022) -
Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment
por: Smith, Eric E., et al.
Publicado: (2020) -
Stroke–Heart Syndrome: Recent Advances and Challenges
por: Scheitz, Jan F., et al.
Publicado: (2022) -
2017 Focused Update for Management of Patients With Valvular Heart Disease: Summary of New Recommendations
por: Matiasz, Richard, et al.
Publicado: (2018)